IJU Case Reports最新文献

{"title":"Solitary fibrous tumor of the bladder: A rare cause of bladder outlet obstruction in an adult male","authors":"Návan van Jaarsveld,&nbsp;Alessandro Pietro Aldera,&nbsp;Jeff John","doi":"10.1002/iju5.12789","DOIUrl":"10.1002/iju5.12789","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Solitary fibrous bladder tumors are extremely uncommon, with only a few cases reported. These fibroblastic mesenchymal neoplasms are typically benign, indolent, and slow growing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case presentation</h3>\u0000 \u0000 <p>A 44-year-old male patient with obstructive uropathy was referred to our unit for workup. Ultrasonography and MRI of the pelvis showed a large, well-circumscribed bladder mass, also visualized cystoscopically. This mass was excised en bloc using the Pfannenstiel approach. Histopathological and immunohistochemical analyses revealed a solitary fibrous tumor.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The management of SFTs can be challenging due to the lack of established guidelines. Hence, we offered our patient long-term follow-up. Twelve months postoperatively, no recurrence or metastases were found on the follow-up imaging.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"11-14"},"PeriodicalIF":0.0,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases”","authors":"Manabu Kato M.D., Ph.D","doi":"10.1002/iju5.12805","DOIUrl":"10.1002/iju5.12805","url":null,"abstract":"<p>Matsumoto <i>et al</i>. reported a case of renal cell carcinoma (RCC) with multiple brain metastases (BMs) treated with stereotactic brain radiation followed by pembrolizumab plus lenvatinib.<span>¹</span> As demonstrated in the Discussion section of this case report, monotherapies with tyrosine kinase inhibitors (TKI), such as cabozantinib, or immune checkpoint inhibitors have exhibited efficacy in improving survival outcomes in the management of BMs from RCC. Therefore, proactive drug treatment for BMs from RCC is warranted. In this regard, Takemura et al. recently reported the outcomes of 389 patients with BMs from RCC utilizing data from the International Metastatic Renal Cell Carcinoma Database Consortium.<span>²</span> In this study, a significant difference in overall survival (OS) was observed between patients with BMs from RCC receiving IO-based combination as first-line drug therapy (32.7 months) compared with those receiving TKI monotherapy (20.6 months). Meanwhile, the group treated with stereotactic radiation or neurosurgery for multiple BMs from RCC showed a longer OS of 31.4 months compared with the group treated with whole brain radiation or no radiation (16.5 months). Yomoet al. reported a longer survival without increase in adverse event after stereotactic brain radiation with IO combination therapy for BMs from RCC.<span>³</span></p><p>Thus far, stereotactic radiation, monotherapy with TKI, or IO have shown effectiveness in controlling BMs in patients with RCC. With more evidence from the aforementioned articles, multimodality treatments composed of stereotactic radiation and IO plus TKI could improve the OS of patients with RCC with multiple BMs.</p><p>Manabu Kato: Writing – review and editing.</p><p>The authors declare no conflict of interest.</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"9-10"},"PeriodicalIF":0.0,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A rare case of retroperitoneal recurrence as squamous cell carcinoma 10 years after nephroureterectomy","authors":"Koichiro Uehara,&nbsp;Tatsuaki Onuki,&nbsp;Yukari Ishibashi,&nbsp;Sayuki Matsunuma,&nbsp;Hiroaki Ishida,&nbsp;Jiro Kumagai,&nbsp;Takayuki Murakami","doi":"10.1002/iju5.12809","DOIUrl":"10.1002/iju5.12809","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Local recurrence for upper tract urothelial carcinoma typically occurs within 2 years post-surgery. We report a rare case of retroperitoneal recurrence as squamous cell carcinoma 10 years after nephroureterectomy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case presentation</h3>\u0000 \u0000 <p>A 67-year-old female was referred to our urology department for a left ureteral tumor. The surgical specimen of the laparoscopic left nephroureterectomy revealed urothelial carcinoma at the pT3 stage. Ten years post-nephroureterectomy, magnetic resonance cholangiopancreatography revealed a mass lesion in the left retroperitoneum, a computed tomography-guided biopsy revealed squamous cell carcinoma. Despite suspected distant metastases of other organ tumors, examinations such as digestive endoscopy and bronchoscopy did not reveal any tumor lesions. The patient was diagnosed with recurrent invasive urothelial carcinoma as a pathological feature of squamous cell carcinoma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The decision-making process for treating malignant tumors, such as in cases with recurrence as squamous cell carcinoma, can be challenging.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"56-59"},"PeriodicalIF":0.0,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnosis of infiltrating bladder endometriosis after fourth cesarean section","authors":"Bassem Skaff,&nbsp;Rayane Diab,&nbsp;Mohamad Moussa,&nbsp;Christopher Massaad,&nbsp;Kariman Ghazal","doi":"10.1002/iju5.12807","DOIUrl":"10.1002/iju5.12807","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This case report highlights the clinical presentation, diagnostic challenges, and effective management of bladder endometriosis, while emphasizing the importance of considering this diagnosis in patients with chronic pelvic pain and urinary symptoms.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A 32-year-old woman presented with severe pelvic pain, dysuria, and dyspareunia. Diagnosis of bladder endometriosis was achieved through clinical suspicion supported by vaginal ultrasound, 3D imaging, and magnetic resonance imaging.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Conservative medical treatment provided temporary relief, which necessitated resection of endometriotic nodule.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Due to its rarity and non-specific presentation, bladder endometriosis is often underdiagnosed or misdiagnosed. In this case, the patient's pain can be correlated with the deeply infiltrating nature of the endometriotic lesions, causing irritation, and involvement of the bladder.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"52-55"},"PeriodicalIF":0.0,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693101/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Late erosion of an Adjustable Transobturator Male System (ATOMS®) device","authors":"Jessica A Paynter,&nbsp;Kirby R Qin,&nbsp;Justin Chee,&nbsp;Todd Manning,&nbsp;Janelle Brennan","doi":"10.1002/iju5.12804","DOIUrl":"10.1002/iju5.12804","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>This report describes late erosion of an Adjustable Transobturator Male System device which was inserted for post-prostatectomy incontinence. The Adjustable Transobturator Male System device eroded the bulbar urethra 5 years post insertion, despite initial improvement of symptoms.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case presentation</h3>\u0000 \u0000 <p>Following an open radical retropubic prostatectomy, a 64 year-old male patient developed post-prostatectomy incontinence. He had a known urethral stricture and had also undergone salvage radiotherapy for biochemical recurrence of prostate cancer. His incontinence was initially successfully treated with an Adjustable Transobturator Male System device, yet this eroded his bulbar urethra 5 years post insertion, which was deemed to be a late erosion.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Urologists should be aware that late erosion of the Adjustable Transobturator Male System device can occur, and risk stratification of patients undergoing Adjustable Transobturator Male System device insertion may help to minimize erosion rates.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"44-46"},"PeriodicalIF":0.0,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693095/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A case of rapidly progressive prostate cancer with bone and lymph node metastasis after contact laser vaporization for benign prostatic hyperplasia","authors":"Kei Muraoka,&nbsp;Akira Fujisaki,&nbsp;Kosuke Uchida,&nbsp;Yasuhiro Hakamata,&nbsp;Yuka Kanda,&nbsp;Kota Sugiura,&nbsp;Masashi Yoshida,&nbsp;Shin Imai,&nbsp;Yoshiro Otsuki,&nbsp;Tatsuaki Yoneda","doi":"10.1002/iju5.12806","DOIUrl":"10.1002/iju5.12806","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Prostate cancer is incidentally diagnosed in 6%–11% of benign prostatic hyperplasia surgeries.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case presentation</h3>\u0000 \u0000 <p>A 79-year-old man was diagnosed with benign prostatic hyperplasia. The prostate volume was 54.5 mL, and the prostate-specific antigen level was 7.121 ng/mL. Magnetic resonance imaging and prostate biopsy were not performed. He then underwent contact laser vaporization of the prostate. After 3 months, gross hematuria occurred, and the prostate-specific antigen level was 62.495 ng/mL. Cystoscopy and magnetic resonance imaging revealed prostate cancer with bladder invasion. Prostate biopsy and transurethral resection were performed, revealing adenocarcinoma with a Gleason score of 5 + 5. The patient was diagnosed with prostate cancer T4N1M1b, and triplet therapy was initiated. After 6 months, the prostate-specific antigen level was 0.037 ng/mL, and the metastases had shrunk.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Vaporization for high-grade prostate cancer can lead to rapid progression. Therefore, screening for prostate cancer before benign prostatic hyperplasia surgery is important.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"47-51"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Initial experience of 980-nm diode laser treatment for recurrent non-muscle-invasive bladder cancer","authors":"Hideo Fukuhara,&nbsp;Yusei Hamada,&nbsp;Syo Shimasaki,&nbsp;Ryohei Iga,&nbsp;Kaya Atagi,&nbsp;Ryu Shigehisa,&nbsp;Yuhi Ota,&nbsp;Shinkuro Yamamoto,&nbsp;Hiroto Osakabe,&nbsp;Tomoya Nao,&nbsp;Tsutomu Shimamoto,&nbsp;Satosi Fukata,&nbsp;Shingo Ashida,&nbsp;Takashi Karashima,&nbsp;Keiji Inoue","doi":"10.1002/iju5.12803","DOIUrl":"10.1002/iju5.12803","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Laser ablation using a 980-nm wavelength diode laser, which is a new-generation laser, for recurrent bladder cancer is known to have a lower incidence of complications and recurrence than conventional transurethral resection of bladder tumor surgery. This is the first study to report the use of 980-nm diode laser ablation for recurrent non-muscle-invasive bladder cancer in Japan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case presentation</h3>\u0000 \u0000 <p>A 73-year-old man underwent transurethral laser ablation for the treatment of recurrent non-muscle-invasive bladder cancer. Laser irradiation was performed using LEONARDO DUAL (diode laser/980-nm wavelength) and a 400-μm BARE laser fiber. Pathological evaluation indicated low-grade urothelial carcinoma, pTa. The patient was discharged on the second postoperative day with no perioperative or postoperative complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This case suggests the potential of transurethral laser ablation for treating recurrent non-muscle-invasive bladder cancer.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"41-43"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ultrasound-guided embolization for renal artery pseudoaneurysm in solitary kidney","authors":"Sana Augustine,&nbsp;Mitwa Patel,&nbsp;Pugazhendi Inban,&nbsp;Sk Sadia Rahman Synthia,&nbsp;Ummul Z Asfeen,&nbsp;Aliza Yaqub,&nbsp;Aadil Mahmood Khan,&nbsp;Mansi Singh","doi":"10.1002/iju5.12796","DOIUrl":"10.1002/iju5.12796","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Renal artery pseudoaneurysm is a rare yet serious complication following percutaneous nephrolithotomy, especially in patients with solitary kidneys. Effective management is crucial to prevent further renal damage.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case presentation</h3>\u0000 \u0000 <p>We report a case of a 41-year-old male with a solitary kidney who experienced gross hematuria and renal insufficiency 3 months after percutaneous nephrolithotomy. Due to the patient's renal insufficiency and the risks associated with arterial catheterization, ultrasound-guided embolization was chosen as the treatment approach. Initial angiographic attempts were impeded by renal vessel spasms, delaying intervention. However, successful direct percutaneous embolization was subsequently performed using ultrasound and digital subtraction angiography.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The patient's recovery was uneventful, and follow-up assessments showed no recurrence of renal artery pseudoaneurysm. This case highlights the effectiveness of ultrasound-guided embolization as a viable treatment option for post-percutaneous nephrolithotomy renal artery pseudoaneurysm, particularly in patients with solitary kidneys.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"19-23"},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vogt-Koyanagi-Harada disease-like uveitis induced by nivolumab in metastatic renal cell carcinoma","authors":"Hitomi Imai,&nbsp;Tomoyuki Koguchi,&nbsp;Yuki Harigane,&nbsp;Kei Yaginuma,&nbsp;Satoru Meguro,&nbsp;Seiji Hoshi,&nbsp;Junya Hata,&nbsp;Hidenori Akaihata,&nbsp;Soichiro Ogawa,&nbsp;Yoshiyuki Kojima","doi":"10.1002/iju5.12801","DOIUrl":"10.1002/iju5.12801","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Nivolumab can cause various immune-related adverse events; it rarely induces Vogt-Koyanagi-Harada-disease-like uveitis. Vogt-Koyanagi-Harada-disease is reported to be closely associated with human leukocyte antigen-DR4.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case presentation</h3>\u0000 \u0000 <p>A 68-year-old man with metastatic renal cancer underwent nephrectomy. Computed tomography showed multiple lung tumors, raising suspicion of lung metastases. However, one lung hilar mass was suspected to be primary lung cancer, leading to a lobectomy, which subsequently revealed lung metastases of renal cancer. The patient underwent nivolumab treatment but developed Vogt-Koyanagi-Harada-disease-like uveitis as an immune-related adverse event. Human leukocyte antigen-DR4 alleles were identified, and the uveitis improved with topical steroids. He maintained partial response of lung metastases after nivolumab resumption. Immunohistochemical staining revealed significantly higher human leukocyte antigen-DR4 expression in lung metastasis than primary renal cancer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Despite inducing Vogt-Koyanagi-Harada-disease-like uveitis, nivolumab controlled cancer progression effectively. Immunohistochemical staining results suggest the potential involvement of human leukocyte antigen-DR4 expression in both the onset of Vogt-Koyanagi-Harada-disease-like uveitis and nivolumab efficacy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"36-40"},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Robot-assisted radical cystectomy using real-time transrectal ultrasound guidance in a patient who had radical prostatectomy and salvage external beam radiation therapy","authors":"Yuta Inoue,&nbsp;Takeshi Yamada,&nbsp;Yuji Okusa,&nbsp;Hideto Taga,&nbsp;Takashi Ueda,&nbsp;Takumi Shiraishi,&nbsp;Atsuko Fujihara,&nbsp;Masayoshi Okumi,&nbsp;Fumiya Hongo,&nbsp;Osamu Ukimura","doi":"10.1002/iju5.12799","DOIUrl":"10.1002/iju5.12799","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Radical cystectomy for patients who previously underwent both radical prostatectomy and prostatic bed radiation is technically challenging.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case presentation</h3>\u0000 \u0000 <p>A 78-year-old man with a history of radical prostatectomy and salvage radiation for prostate cancer was referred to our hospital for radical treatment of bladder cancer. After two cycles of neoadjuvant chemotherapy, he underwent robot-assisted radical cystectomy with real-time transrectal ultrasound guidance during dissection of the rectovesical space to minimize the risk of rectal injury. There were no perioperative adverse events.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Intraoperative real-time transrectal ultrasound guidance could assist surgeons to safely perform the dissection of the rectovesical space in the surgically high-risk patient.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 1","pages":"28-31"},"PeriodicalIF":0.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}